Reed's Inc. (REED)
REED trades on NYSE in Consumer Staples, Beverages (Production/Distribution). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5720
-4.49% on the day
Market cap
$6.8M
Nano cap
Revenue · 2025
$34.1M
-10.2% on 2024
Net income · 2025
-$15.8M
-46.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | REED on NYSE |
| Sector | Consumer Staples |
| Industry | Beverages (Production/Distribution) |
| Country | Not reported by the screener |
| IPO year | 2025 |
| SEC CIK | 0001140215 |
| SEC industry code | Bottled & Canned Soft Drinks & Carbonated Waters |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $34.1M |
| Net income | -$15.8M |
| Operating income | -$15.1M |
| Net margin | -46.5% |
| Operating margin | -44.5% |
| Revenue growth | -10.2% |
| Cash | Not in SEC XBRL data |
| Total assets | $23.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-12-05 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Beverages (Production/Distribution)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AMSS | AMASS Brands Inc. | $0.3719 | +7.42% | $4.3M |
| IBG | Innovation Beverage Group Limited | $0.8800 | +2.33% | $3.7M |
| WVVIP | Willamette Valley Vineyards Inc. Series A Redeemable Preferred Stock | $2.72 | +1.49% | $13.5M |
| EPSM | Epsium Enterprise Limited | $1.14 | 0.00% | $15.3M |
| YHC | LQR House Inc. | $1.90 | +22.58% | $2.5M |
| IPST | IP Strategy Holdings Inc. | $2.82 | -1.05% | $2.0M |
| SRXH | SRX Global Inc. | $1.37 | +0.73% | $27.8M |
| EDVA | Endovia Health Sciences Inc. | $0.1414 | -3.15% | $1.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier